Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
48.31
-0.19 (-0.39%)
Sep 4, 2026, 11:17 AM EDT - Market open
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Rigel Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $63. The average 1-year stock price forecast is 30.41% higher than the current stock price, while the lowest is $43 (-10.99%) and the highest is $85 (+75.95%).
Price Target: $63 (+30.41%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $40 → $49 | Hold | Maintains | $40 → $49 | +1.43% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $57 → $85 | Buy | Reiterates | $57 → $85 | +75.95% | Aug 14, 2026 |
| Citi | Citi | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +71.81% | Aug 6, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $43 | Hold | Maintains | $43 | -10.99% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
305.73M
from 294.28M
Increased by 3.89%
Revenue Next Year
372.84M
from 305.73M
Increased by 21.95%
EPS This Year
3.54
from 6.43
Decreased by -44.90%
EPS Next Year
4.94
from 3.54
Increased by 39.42%
EPS and Forward PE are based on non-GAAP adjusted numbers.